Visus Therapeutics
Closed- Headquarters
- Warren, New Jersey
- Employees
- 11–50
- Business Model
- B2B
- Website
- visustx.com
About
Visus Therapeutics, Inc. is a Warren, New Jersey-based ophthalmic pharmaceutical company developing paradigm-shifting therapeutics for vision conditions with significant unmet medical need, including presbyopia, cataracts, and geographic atrophy. The company's lead product, YUVEZZI (carbachol and brimonidine tartrate ophthalmic solution), targets presbyopia — a gradual loss of near visual acuity affecting millions of aging adults. Visus Therapeutics operates as an affiliate of Tenpoint Therapeutics, Ltd., a global commercial-stage ophthalmic company. The company works in partnership with eye care professionals including optometrists and ophthalmologists.
Summary
Visus Therapeutics is a Biotech company based in Warren, United States.
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform

Specialty pharmaceutical company